🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Noura J. Choudhury

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-5980-4973

Also affiliated with University of Chicago, University of Chicago Medical Center, University of Chicago Medicine Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.3Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0580
Top 16%
1.3DataRank
Top 16%36 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +24 more

Papers

Driven by 16 papers — median percentile 0. Top paper: “Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial”.

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00249-3
N/A
1.4DataRank · unranked
50 citations

Mark Dunphy, Matthew Agee, Joseph O'Donoghue, Rania G. Aly, Noura J. Choudhury +14 more

The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0580
Top 16%
1.3DataRank
Top 16%36 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +24 more

Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.10.012
N/A
0.208DataRank · unranked
3 citations

Jake June-Koo Lee, Noura J. Choudhury, Angela B. Hui, Mark Jeng, Jennifer Zheng +20 more

Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9100
N/A
0DataRank · unranked
0 citations

Antonio Marra, Soo‐Ryum Yang, Christina J. Falcon, Glenn Heller, Mark G. Kris +4 more

Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.05.008
N/A
0DataRank · unranked
88 citations

David Balli, W. Victoria Lai, Allison L. Richards, Evelyn M. Nguyen, Jacklynn V. Egger +8 more

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100546
N/A
0DataRank · unranked
4 citations

Noura J. Choudhury, Fiona Ehrich, Tyler Beardslee, Danielle Brazel, Shannon Zhang +8 more

ctDNA analysis of NTRK fusion and mechanisms of acquired resistance to TRK inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3062
N/A
0DataRank · unranked
2 citations

Guilherme Harada, Noura J. Choudhury, Casey Savin, Ronak Shah, Michael F. Berger +2 more

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100187
N/A
0DataRank · unranked
33 citations

Jaime L. Schneider, Tejas Patil, Viola W. Zhu, Debra A. Goldman, Soo-Ryum Yang +13 more

Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6742700
Top 100%
0DataRank
Top 100%0 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +23 more

Chromothripsis-Mediated Small Cell Lung Carcinoma

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0286
N/A
0DataRank · unranked
45 citations

Sam E. Tischfield, Christopher A. Febres‐Aldana, Jake June-Koo Lee, Jason C. Chang, Benjamin Herzberg +37 more

First-in-human imaging with [ 89 Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate

medRxiv(2024)10.1101/2024.01.10.24301109
N/A
0DataRank · unranked
4 citations

Mark Dunphy, Matthew Agee, Joseph A. O’Donoghue, Rania G. Aly, Noura J. Choudhury +14 more

Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases

Annals of Oncology(2025)10.1016/j.annonc.2025.06.001
N/A
0DataRank · unranked
9 citations

Mark Jeng, S Tischfield, J.S.Y. Sui, Dmitry Nemirovsky, Glenn Heller +9 more

Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.010
N/A
0DataRank · unranked
5 citations

Rohit Thummalapalli, Christopher A. Febres‐Aldana, Daniel M. Muldoon, Christina J. Falcon, Amanda Pupo +18 more

Data from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6742700.v1
Top 100%
0DataRank
Top 100%0 citations

Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran +23 more

Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.022
N/A
0DataRank · unranked
99 citations

Antonio Marra, Jane Sze Yin Sui, Jessica Flynn, Soo‐Ryum Yang, Christina J. Falcon +14 more

Mechanisms of acquired resistance to TRK inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3104
N/A
0DataRank · unranked
17 citations

Noura J. Choudhury, Alison M. Schram, Ezra Y. Rosen, Yonina R. Murciano‐Goroff, Christina J. Falcon +13 more